facebook linkedin twitter

FDA is Taking Steps to Ensure Safe COVID-19 Vaccines for Children

September 10, 2021 by Reece Nations
Dr. Peter Marks, director of the Center for Biologics Evaluation and Research in the Food and Drug Administration, provides an update on efforts to combat COVID-19 on Capitol Hill in Washington. (Jim Lo Scalzo/Pool via AP)

WASHINGTON — With the public school year already underway around the country, the Food and Drug Administration is not taking chances when it comes to making COVID-19 vaccinations available to children younger than 12 years old.

Acting FDA Commissioner Janet Woodcock and the FDA director of the Center for Biologics Research and Evaluation, Peter Marks, released a joint statement on Friday providing clarity on the administration’s initiative to safely make COVID-19 immunizations available to young children and adolescents.

“Many of our team at the FDA are parents and grandparents themselves, and our team shares the same concerns as many in our country about protecting our loved ones from COVID-19,” Woodcock and Marks said in a written statement. “We are therefore also eager to see COVID-19 vaccines available for young children. We also know that we all share the interest in making sure this process is done with safety at top of mind.”

The FDA officials continued, “As regulators, we recognize we have an important task ahead of us that will require us to act expeditiously while undertaking an extremely meticulous and thoughtful review once we receive requests to authorize a COVID-19 vaccine for emergency use or submissions for approval of a COVID-19 vaccine for this population.”

In their release, the FDA officials announced that clinical trials with child participants are currently underway and the process will entail a follow-up period of around two months at least to “allow for proper safety monitoring following the administration” of the doses. Following a complete analysis of the data by vaccine manufacturers, the FDA will work closely with the producers to ensure the immunizations meet regulatory standards.

Following a robust examination of the clinical trials, the manufacturers can request an emergency use authorization or submit a biologics license application for approval with the FDA. After the approval requests are received, the FDA will complete independent evaluations of the data to determine the benefits and risks of the vaccine before ratifying the approvals “in a matter of weeks rather than months.”

“It’s important that the public recognize that, because young children are still growing and developing, it’s critical that thorough and robust clinical trials of adequate size are completed to evaluate the safety and the immune response to a COVID-19 vaccine in this population,” Woodcock and Marks said in a written statement. “Children are not small adults – and issues that may be addressed in pediatric vaccine trials can include whether there is a need for different doses or different strength formulations of vaccines already used for adults.”

The FDA’s ability to review the applications in a timely manner depends in part on the readiness and quality of the manufacturers’ submissions, the agency’s officials said. When a vaccine authorization for younger populations has been approved, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will meet to discuss further clinical recommendations.

Different dosing regimens were approved for individuals aged 12 years and older than the ones being studied for younger individuals, and FDA officials will conduct a “thorough evaluation” to ensure the vaccines do not cause unexpected safety issues separate from those already observed in adolescents and adults.

“Until we authorize or approve a vaccine for this younger population, it’s especially important that parents and others who interact closely with children under 12 years of age get vaccinated, wear masks, and follow other recommended precautions so that we can protect those who cannot yet protect themselves through vaccination,” Woodcock and Marks concluded in their release. 

Health

September 24, 2021
by Tom Ramstack
CDC Director Overrides Vote to Broaden Eligibility for Vaccines

ATLANTA, Ga.-- Dr. Rochelle Walensky made an unusual break Friday from a U.S. Centers for Disease Control and Prevention advisory... Read More

ATLANTA, Ga.-- Dr. Rochelle Walensky made an unusual break Friday from a U.S. Centers for Disease Control and Prevention advisory panel by overruling its guidance on booster doses for the Pfizer/BioNTech's COVID-19 vaccine. The Advisory Committee on Immunization Practices approved the boosters Thursday for anyone 65... Read More

Biden Urges COVID-19 Booster Shots for Those Now Eligible

WASHINGTON (AP) - President Joe Biden on Friday urged those now eligible for COVID-19 booster shots to get the added... Read More

WASHINGTON (AP) - President Joe Biden on Friday urged those now eligible for COVID-19 booster shots to get the added protection a day after the Centers for Disease Control and Prevention endorsed the doses for millions of older or otherwise vulnerable Americans.  Opening a major new... Read More

September 23, 2021
by Reece Nations
Centers for Medicare and Medicaid Service to Distribute Federal Funding to Rural Hospitals

The Centers for Medicare and Medicaid Services is disbursing an initial amount of $2 million to four health care entities... Read More

The Centers for Medicare and Medicaid Services is disbursing an initial amount of $2 million to four health care entities in four states to bolster access to their services in underserved communities. Funds will be distributed to participating hospitals in rural areas to overhaul their health... Read More

September 22, 2021
by Tom Ramstack
Protecting Children During Pandemic Guides Policy at Congressional Hearing

WASHINGTON -- A congressional panel on Wednesday examined whether the federal government’s strategy is appropriate for protecting children during the... Read More

WASHINGTON -- A congressional panel on Wednesday examined whether the federal government’s strategy is appropriate for protecting children during the COVID-19 pandemic. Lawmakers asked about the potential for vaccinating children, having them return safely to school and whether they should wear masks. The update they sought... Read More

September 22, 2021
by Alexa Hornbeck
OSHA Will Issue Federal Heat Standard for U.S. Workplaces 

WASHINGTON -- Extreme heat has played a role in worsening health outcomes, especially for minority communities and for construction and... Read More

WASHINGTON -- Extreme heat has played a role in worsening health outcomes, especially for minority communities and for construction and farm workers at risk of heat stroke.  In response to rising temperatures due to climate change, the Occupational Safety and Health Administration is set to issue... Read More

September 22, 2021
by Alexa Hornbeck
NIH Invests $1.67 Million to Study How Vaccines Impact the Menstrual Cycle 

WASHINGTON -- The NIH recently invested $1.67 million in five institutions to explore the link between COVID-19 vaccines and menstruation... Read More

WASHINGTON -- The NIH recently invested $1.67 million in five institutions to explore the link between COVID-19 vaccines and menstruation changes, as some women are reporting irregular or missing menstrual periods after receiving a vaccine.  Only a few weeks after the NIH investment was released, an... Read More

News From The Well
scroll top